Financial Daily from THE HINDU group of publications
Monday, Oct 28, 2002

News
Features
Stocks
Port Info
Archives

Group Sites

Opinion - Letters


Promote ayurveda

This is with regard to the report "Stringent guidelines for ayurveda drugs soon" (Business Line, October 24). While it is desirable that guidelines should be laid down for the manufacture of ayurvedic drugs, they should not impede growth.

Also, with the cost of allopathic drugs increasing exorbitantly, the poor need an alternative and cheaper system of medicine.

There is already a wealth of literature on ayurveda, but it is mostly in Sanskrit. The Centre should appoint a committee of eminent ayurvedic physicians to translate them into various vernacular languages.

The fact that ayurveda contributes about $60 billion of the estimated $120 billion annual global herbal market should be borne in mind, and steps taken to increase India's share in it, which at present is only 5 per cent.

T. R. Anandan

Coimbatore

Send this article to Friends by E-Mail
Comment on this article to BLFeedback@thehindu.co.in

Stories in this Section
Preparing a pension plan


Bitter-sweet policy
A world adrift
Ganga-Cauvery link: A master plan for growth
How secure is information?
The IPR effect on drug prices
IPRs losing ground
`Construction industry must build on technology' — Mr A. Ramakrishna, President (Operations) and Deputy MD, L & T
Promote ayurveda
Mediclaim policies


The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | The Sportstar | Frontline | Home |

Copyright 2002, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line